<DOC>
	<DOCNO>NCT02620605</DOCNO>
	<brief_summary>Study effect early cabergoline administration prevention occurrence decrease severity OHSS patient undergo intra cytoplasmic sperm injection.And effect oocyte maturation , fertilization pregnancy rate..</brief_summary>
	<brief_title>The Influence Timing Cabergoline Initiation Prevention OHSS</brief_title>
	<detailed_description>Patients le 35years undergoing Intra Cytoplasmic Sperm Injection infertility schedule gonadotropin release hormone agonist long protocol ovarian stimulation . All patient receive combine oral contraceptive pill ( Gynera , Schering-plow : plough ) start day 5 cycle precedes stimulate cycle .On day 21 cycle patient start receive Gonadotrophin release hormone agonist form ( decapeptyl 0.1 sc daily continue till day HCG administration ) . To ensure patient completely regulate desensitized , trans-vaginal ultrasound perform day 2-3 menses stimulate cycle ensure endometrial thickness le 5 mm ovarian cysts.Also serum E2 level le 50 pg/ml . Then patient start receive Gonadotrophin ( HMG ) ( Menogon , ferring pharmaceutical , Germany ) 225 IU ( international unit ) Intramuscular Injection daily , continuous schedule follow ovarian response serial trans -vaginal US ass follicular growth together serial serum E2 start day 6 cycle onwards.With adjustment gonadotropin dose monitoring frequency base patient response . During follow recruit patient fulfil inclusion criterion ( serum E2 equal 4000 pg/ml /or 18 follicle 11 mm diameter day stimulation ) , allocate randomly computer generate card assign seal envelope treat doctor outpatient clinic . Group A : receive cabergoline 0.5 mg/day 8 day , start day HCG ( human chorionic gonadotropin ) injection . Group B : receive cabergoline 0.5 mg/day criterion inclusion criterion fulfil continued till day human chorionic gonadotropin ( HCG ) trigger continue 8 day day trigger .</detailed_description>
	<mesh_term>Syndrome</mesh_term>
	<mesh_term>Ovarian Hyperstimulation Syndrome</mesh_term>
	<mesh_term>Cabergoline</mesh_term>
	<criteria>Female le 35 year go Intra cytoplasmic sperm injection cycle infertility ( tubal factor un explain infertility ) . 18 oocyte 11 mm diameter and/or E2 4000 pg/ml day stimulation cycle HCG trigger patient one ovary patient already receive cabergoline treatment Severe Male factor infertility . Thyroid dysfunction .</criteria>
	<gender>Female</gender>
	<minimum_age>19 Years</minimum_age>
	<maximum_age>35 Years</maximum_age>
	<verification_date>February 2017</verification_date>
	<keyword>Cabergoline</keyword>
	<keyword>Ovarian Hyper Stimulation Syndrome ( OHSS )</keyword>
</DOC>